| 000 | 01102 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517111936.0 | ||
| 264 | 0 | _c20170508 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1177-8881 | ||
| 024 | 7 |
_a10.2147/DDDT.S61443 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEbstie, Yehenew A | |
| 245 | 0 | 0 |
_aTafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date. _h[electronic resource] |
| 260 |
_bDrug design, development and therapy _c2016 |
||
| 300 |
_a2387-99 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAminoquinolines _xadministration & dosage |
| 650 | 0 | 4 |
_aAntimalarials _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalaria, Vivax _xdrug therapy |
| 650 | 0 | 4 |
_aPlasmodium vivax _xdrug effects |
| 700 | 1 | _aAbay, Solomon M | |
| 700 | 1 | _aTadesse, Wondmagegn T | |
| 700 | 1 | _aEjigu, Dawit A | |
| 773 | 0 |
_tDrug design, development and therapy _gvol. 10 _gp. 2387-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S61443 _zAvailable from publisher's website |
| 999 |
_c26331897 _d26331897 |
||